Search

everythinglearnresearchcommunity

for

Search:↓

A vaccine may prevent benign prostatic hyperplasia (BPH).

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Hsc70 protein may influence hair growth by responding to androgens.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Testosterone helps human pancreatic cells increase insulin release.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Finasteride may cause kidney damage.

The availability of certain hormones and specific stimulation patterns affect long-term synaptic changes in the male rat brain.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Korean and Caucasian men with male pattern baldness have different hair steroid levels.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Lowering certain hormone levels improves treatment for hair loss in young men.

Stem cell therapy could be a promising alternative for hair regrowth with fewer side effects.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Cutaneous calcinosis can be induced in young animals using certain compounds, but only in specific areas and with high mortality.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.